Journal article

Antibody inhibiting enzymatic activity of tumour-associated carbonic anhydrase isoform IX

MT Murri-Plesko, A Hulikova, E Oosterwijk, AM Scott, A Zortea, AL Harris, G Ritter, L Old, S Bauer, P Swietach, C Renner

European Journal of Pharmacology | ELSEVIER | Published : 2011

Abstract

Carbonic anhydrase IX (CAIX) is a hypoxia-induced, membrane-tethered enzyme that is highly expressed in many cancers. It catalyses the hydration of CO 2 to HCO3- and H+, and the reverse dehydration reaction. Recent studies have shown an important role for CAIX in pH regulation and it has been speculated that CAIX may play a role in supporting cancer progression towards more aggressive forms of the disease. Clinical correlative studies in many tumours have shown that high expression is related to poor outcome. In the present study, we have selected antigen-binding antibody fragments (Fab) against human CAIX by phage-display, and tested these for inhibitory potency on CAIX catalytic activity. ..

View full abstract

University of Melbourne Researchers

Grants

Awarded by Ludwig Institute for Cancer Research


Funding Acknowledgements

This work was funded in part by "Forschungskredit Universitat Zurich/Baugarten Stiftung" (CR), Ludwig Institute for Cancer Research (CR), the Royal Society (PS) and Medical Research Council, UK (PS). We would like to thank Roland Wenger, Daniel Stiehl and Patrick Spielmann (Institute of Physiology University Zurich) for helpful comments and advise.